|
Feb 20
|
Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research
|
|
Jan 5
|
Voyager Therapeutics Announces Pricing of Public Offering
|
|
Jan 4
|
Voyager Therapeutics Announces Proposed Public Offering
|
|
Jan 4
|
Biotech Stock Roundup: VYGR Gains From NVS Deal, AGIO Up on Study Data & More
|
|
Jan 2
|
UPDATE 2-Novartis signs gene therapy deal with Voyager for $100 mln upfront
|
|
Jan 2
|
Voyager Therapeutics shares jump after $1.2 billion deal with Novartis
|
|
Jan 2
|
Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies
|
|
Dec 8
|
12 Best Healthcare Stocks For the Long-Term
|
|
Dec 6
|
Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program
|
|
Aug 22
|
11 Most Undervalued Biotech Stocks to Buy According to Analysts
|
|
Aug 19
|
Institutional investors own a significant stake of 43% in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
|
|
May 25
|
Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
|